Cargando…

Impaired Insulin Secretion and Enhanced Insulin Sensitivity in Cholecystokinin-Deficient Mice

OBJECTIVE: Cholecystokinin (CCK) is released in response to lipid intake and stimulates insulin secretion. We hypothesized that CCK deficiency would alter the regulation of insulin secretion and glucose homeostasis. RESEARCH DESIGN AND METHODS: We used quantitative magnetic resonance imaging to dete...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Chun-Min, Obici, Silvana, Dong, H. Henry, Haas, Michael, Lou, Dawnwen, Kim, Dae Hyun, Liu, Min, D’Alessio, David, Woods, Stephen C., Tso, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121422/
https://www.ncbi.nlm.nih.gov/pubmed/21602512
http://dx.doi.org/10.2337/db10-0789
_version_ 1782206820259987456
author Lo, Chun-Min
Obici, Silvana
Dong, H. Henry
Haas, Michael
Lou, Dawnwen
Kim, Dae Hyun
Liu, Min
D’Alessio, David
Woods, Stephen C.
Tso, Patrick
author_facet Lo, Chun-Min
Obici, Silvana
Dong, H. Henry
Haas, Michael
Lou, Dawnwen
Kim, Dae Hyun
Liu, Min
D’Alessio, David
Woods, Stephen C.
Tso, Patrick
author_sort Lo, Chun-Min
collection PubMed
description OBJECTIVE: Cholecystokinin (CCK) is released in response to lipid intake and stimulates insulin secretion. We hypothesized that CCK deficiency would alter the regulation of insulin secretion and glucose homeostasis. RESEARCH DESIGN AND METHODS: We used quantitative magnetic resonance imaging to determine body composition and studied plasma glucose and insulin secretion of CCK gene knockout (CCK-KO) mice and their wild-type controls using intraperitoneal glucose and arginine infusions. The area of anti-insulin staining in pancreatic islets was measured by immunohistochemistry. Insulin sensitivity was assessed with euglycemic-hyperinsulemic clamps. RESULTS: CCK-KO mice fed a low-fat diet had a reduced acute insulin response to glucose but a normal response to arginine and normal glucose tolerance, associated with a trend toward greater insulin sensitivity. However, when fed a high-fat diet (HFD) for 10 weeks, CCK-KO mice developed glucose intolerance despite increased insulin sensitivity that was associated with low insulin secretion in response to both glucose and arginine. The deficiency of insulin secretion in CCK-KO mice was not associated with changes in β-cell or islet size. CONCLUSIONS: CCK is involved in regulating insulin secretion and glucose tolerance in mice eating an HFD. The impaired insulin response to intraperitoneal stimuli that do not typically elicit CCK release suggests that this hormone has chronic effects on β-cell adaptation to diet in addition to acute incretin actions.
format Online
Article
Text
id pubmed-3121422
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-31214222012-07-01 Impaired Insulin Secretion and Enhanced Insulin Sensitivity in Cholecystokinin-Deficient Mice Lo, Chun-Min Obici, Silvana Dong, H. Henry Haas, Michael Lou, Dawnwen Kim, Dae Hyun Liu, Min D’Alessio, David Woods, Stephen C. Tso, Patrick Diabetes Genetics OBJECTIVE: Cholecystokinin (CCK) is released in response to lipid intake and stimulates insulin secretion. We hypothesized that CCK deficiency would alter the regulation of insulin secretion and glucose homeostasis. RESEARCH DESIGN AND METHODS: We used quantitative magnetic resonance imaging to determine body composition and studied plasma glucose and insulin secretion of CCK gene knockout (CCK-KO) mice and their wild-type controls using intraperitoneal glucose and arginine infusions. The area of anti-insulin staining in pancreatic islets was measured by immunohistochemistry. Insulin sensitivity was assessed with euglycemic-hyperinsulemic clamps. RESULTS: CCK-KO mice fed a low-fat diet had a reduced acute insulin response to glucose but a normal response to arginine and normal glucose tolerance, associated with a trend toward greater insulin sensitivity. However, when fed a high-fat diet (HFD) for 10 weeks, CCK-KO mice developed glucose intolerance despite increased insulin sensitivity that was associated with low insulin secretion in response to both glucose and arginine. The deficiency of insulin secretion in CCK-KO mice was not associated with changes in β-cell or islet size. CONCLUSIONS: CCK is involved in regulating insulin secretion and glucose tolerance in mice eating an HFD. The impaired insulin response to intraperitoneal stimuli that do not typically elicit CCK release suggests that this hormone has chronic effects on β-cell adaptation to diet in addition to acute incretin actions. American Diabetes Association 2011-07 2011-06-20 /pmc/articles/PMC3121422/ /pubmed/21602512 http://dx.doi.org/10.2337/db10-0789 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
spellingShingle Genetics
Lo, Chun-Min
Obici, Silvana
Dong, H. Henry
Haas, Michael
Lou, Dawnwen
Kim, Dae Hyun
Liu, Min
D’Alessio, David
Woods, Stephen C.
Tso, Patrick
Impaired Insulin Secretion and Enhanced Insulin Sensitivity in Cholecystokinin-Deficient Mice
title Impaired Insulin Secretion and Enhanced Insulin Sensitivity in Cholecystokinin-Deficient Mice
title_full Impaired Insulin Secretion and Enhanced Insulin Sensitivity in Cholecystokinin-Deficient Mice
title_fullStr Impaired Insulin Secretion and Enhanced Insulin Sensitivity in Cholecystokinin-Deficient Mice
title_full_unstemmed Impaired Insulin Secretion and Enhanced Insulin Sensitivity in Cholecystokinin-Deficient Mice
title_short Impaired Insulin Secretion and Enhanced Insulin Sensitivity in Cholecystokinin-Deficient Mice
title_sort impaired insulin secretion and enhanced insulin sensitivity in cholecystokinin-deficient mice
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3121422/
https://www.ncbi.nlm.nih.gov/pubmed/21602512
http://dx.doi.org/10.2337/db10-0789
work_keys_str_mv AT lochunmin impairedinsulinsecretionandenhancedinsulinsensitivityincholecystokinindeficientmice
AT obicisilvana impairedinsulinsecretionandenhancedinsulinsensitivityincholecystokinindeficientmice
AT donghhenry impairedinsulinsecretionandenhancedinsulinsensitivityincholecystokinindeficientmice
AT haasmichael impairedinsulinsecretionandenhancedinsulinsensitivityincholecystokinindeficientmice
AT loudawnwen impairedinsulinsecretionandenhancedinsulinsensitivityincholecystokinindeficientmice
AT kimdaehyun impairedinsulinsecretionandenhancedinsulinsensitivityincholecystokinindeficientmice
AT liumin impairedinsulinsecretionandenhancedinsulinsensitivityincholecystokinindeficientmice
AT dalessiodavid impairedinsulinsecretionandenhancedinsulinsensitivityincholecystokinindeficientmice
AT woodsstephenc impairedinsulinsecretionandenhancedinsulinsensitivityincholecystokinindeficientmice
AT tsopatrick impairedinsulinsecretionandenhancedinsulinsensitivityincholecystokinindeficientmice